Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received successful trial results for its new bone treatment medicine. The drug, called BP16, is a biosimilar of an existing ...

Oct. 30, 2019 — About half of all women in the U.S. will suffer a bone fracture due to osteoporosis. For women, the incidence of this condition is greater than that of heart attack, stroke and breast ...